RE: Delivering on commercial strategy23 Jun 2022 10:17
General tech market malaise- lazy assumption that all tech stocks are the same - OTC listing in the US seems to have attracted the automated trades that short sellers use. Like Angle no TR1s despite the massive dumping over the last couple of months. Absolutely zero recognition among UK retail investors - anything over 3% held by institutional investors, no retail investor platform holdings.
It's a great way to invest in unlisted UK and European companies like Graphcore, Revolut, Thought Machine, Form3, Aiven and Endomag (recently had their pre-op breast cancer tech approved by Nice)
I have traded in and out of it a few times and have always regretted not being invested when have sold out.